PTEN and neoplasm: In conclusion, using our mouse model with Ad-TgP-Cre, we show that postnatal expression of BRAFV600E alone under physiologic TSH levels is sufficient for development of thyroid cancer and that simultaneous reduced expression of PTEN tends to promote tumor growth and de-differentiation.